This site is part of the Siconnects Division of Sciinov Group

This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.

ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR

Registration

Europe Neurological Biomarkers Forecast, 2022 - 2028

$2999

The Asia Pacific Neurological Biomarkers Market would witness market growth of 15.0% CAGR during the forecast period (2022-2028).

The China market dominated the Asia Pacific Neurological Biomarkers Market by Country in 2021; thereby, achieving a market value of $1,010 Million by 2028. The Japan market is anticipated to grow at a CAGR of 14.3% during (2022 - 2028). Additionally, The India market would obtain a CAGR of 15.7% during (2022 - 2028).

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. HOFFMANN-LA ROCHE LTD., Bio-Rad Laboratories, Inc., Merck Group, PERKINELMER INC., Shimadzu corporation, Thermo Fisher Scientific, Inc., Quanterix Corporation, Neuro-Bio Ltd., BioMérieux S.A. and Myriad Genetics, Inc.


RELATED PRODUCTS

You may also be interested in:

Subscribe to our News & Updates